Harm Reduction and the American Difference: Drug Treatment and Problem-Solving Courts in Comparative Perspective by Noland, James L., Jr.
Journal of Health Care Law and Policy
Volume 13 | Issue 1 Article 4
Harm Reduction and the American Difference:
Drug Treatment and Problem-Solving Courts in
Comparative Perspective
James L. Noland Jr.
Follow this and additional works at: http://digitalcommons.law.umaryland.edu/jhclp
Part of the Health Law Commons, and the Substance Abuse and Addiction Commons
This Conference is brought to you for free and open access by DigitalCommons@UM Carey Law. It has been accepted for inclusion in Journal of
Health Care Law and Policy by an authorized administrator of DigitalCommons@UM Carey Law. For more information, please contact
smccarty@law.umaryland.edu.
Recommended Citation
James L. Noland Jr., Harm Reduction and the American Difference: Drug Treatment and Problem-Solving Courts in Comparative Perspective,
13 J. Health Care L. & Pol'y 31 (2010).
Available at: http://digitalcommons.law.umaryland.edu/jhclp/vol13/iss1/4
HARM REDUCTION AND THE
AMERICAN DIFFERENCE: DRUG
TREATMENT AND PROBLEM-
SOLVING COURTS IN COMPARATIVE
PERSPECTIVE
JAMES L. NOLAN, JR.*
INTRODUCTION
In my recent book, Legal Accents, Legal Borrowing, I examine the
development of problem-solving courts in the United States and observe the
process by which these courts have been exported to five other common law
countries: England, Scotland, Ireland, Canada, and Australia.' A comparison of the
development of problem-solving courts in these six cases reveals an important
difference between the U.S. and the other countries as it concerns the salience of
defining treatment philosophies.2 In the five non-U.S. regions, one finds a treatment
philosophy-typically characterized as "harm reduction" or "harm
minimization"-that is clearly distinct from the sort of sensibilities and treatment
practices common in the U.S. 3 The harm reduction approach popular in these other
Copyright © 2010 by James L. Nolan, Jr.
* Professor of Sociology and Chair of the Department of Anthropology and Sociology at Williams
College. Between 1999 and 2008 1 visited over fifty problem-solving courts in six common law
countries: England, Scotland, Ireland, Canada, Australia, and the United States. Quotes in this Article
are taken from statements made at local problem-solving court sites that I visited (i.e., either in
interviews with the author or in statements made during court sessions, community meetings, court
launchings, pre-court meetings, or treatment sessions) or at regional, national, or international
conferences (i.e., either in interviews with the author or in statements made during speeches or panel
discussions). Portions of this Article include revised material from JAMES L. NOLAN JR., LEGAL
ACCENTS, LEGAL BORROWING: THE INTERNATIONAL PROBLEM-SOLVING COURT MOVEMENT (2009)
and James L. Nolan, Jr., Separated by an Uncommon Law: Drug Courts in Great Britain and America,
in DRUG COURTS: IN THEORY AND IN PRACTICE 89-112 (James L. Nolan, Jr. ed., 2002).
I. See generally JAMES L. NOLAN JR., LEGAL ACCENTS, LEGAL BORROWING: THE
INTERNATIONAL PROBLEM-SOLVING COURT MOVEMENT (2009) (tracing the development of problem-
solving courts in the United States and abroad).
2. See id. at 136 (contrasting the enthusiastic, bold, and pragmatic approach used in the U.S. with
the moderate, deliberate, and restrained approach used by other countries).
3. Id. at 77, 102, 148 (explaining the difference between the system in the U.S., which
concentrates on total abstinence, and the various systems in England, Canada, and Australia, which
utilize harm reduction or harm minimization methods).
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countries manifests itself in a number of ways, including in the defining practices
of new problem-solving court programs.4
By most accounts, the problem-solving court movement began in 1989 in
Dade County, Florida, with the initiation of America's first drug court.5 Since then,
the burgeoning drug court movement has expanded in two important directions.
6
First, a number of other specialty courts-largely based on the drug court model-
have been developed throughout the United States, the most prominent of which
are community courts, domestic violence courts, and mental health courts.
7
Currently, there are more than three thousand problem-solving courts in the U.S.
8
Second, over the past decade, a variety of problem-solving courts have been
exported internationally. 9 England, Scotland, Ireland, Canada, and Australia are
among the countries where this process of legal transplantation is most advanced.' °
Although problem-solving courts vary considerably from place to place, it
generally has been observed, particularly in the U.S., that these courts share five
common features: (1) close and ongoing judicial monitoring, (2) a multidisciplinary
or team-oriented approach, (3) a therapeutic or treatment orientation, (4) the
altering of traditional roles in the adjudication process, and (5) an emphasis on
solving the problems of individual offenders."1 In the process of transplanting these
courts, importers have attempted to adapt or indigenize the American model to suit
the conditions of their local legal-cultural context.' 2 One important difference
revealed in this process of adaptation is the extent to which the countries outside of
the U.S. embrace a harm reduction philosophy. 3
4. See, e.g., id. at 102-04 (discussing the Australian harm reduction strategy of moving prostitutes
who are caught working on the streets to the relatively more safe brothels, and the Canadian harm
reduction programs in Toronto and Vancouver, which allow intravenous drug users a safe and clean
injection site so as to prevent the spread of HIV).
5. NAT'L INST. OF JUSTICE, U.S. DEP'T OF JUSTICE, DRUG COURTS: THE SECOND DECADE 1
(2006); Greg Berman & John Feinblatt, Problem-Solving Courts: A Brief Primer, 23 LAW & POL'Y 125,
126 (2001).
6. See infra notes 7-10 and accompanying text.
7. NOLAN, supra note 1, at 12, 14, 17.
8. Id. at 20.
9. See id. at 87-88 (discussing comments by an Australian judge regarding the expansion of
problem-solving courts in Australia over the past decade and crediting the U.S. as the source of the
problem-solving court movement).
10. See infra notes 15-23, 25-28, 36-44, 61-69, 75-82 and accompanying text.
11. NOLAN, supra note 1, at 10-12.
12. See id. at 49, 119, 166 (discussing the development of the British, Canadian, and Scottish drug
courts and the adaptation of the American system to suit local needs).
13. Id. at 148 ("Another example of the contrast between American boldness and the relative
moderation of the other countries is the differing treatment goals: total abstinence in the United States,
and harm reduction or harm minimization in other countries."); see also id. at 102-04 (discussing the
adaptation of the American drug court in Australia and Canada).
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This approach is evident in a variety of problem-solving court venues. 4 One
of the more interesting can be found in Melbourne, Australia's prostitution court.
15
Euphemistically referred to as the "Tuesday afternoon list, ' 6 this court-based
program is overseen by Magistrate Jelena Popovic, 7 whose judicial orientation is
clearly guided by a harm minimization perspective.' 8 Popovic explains that there
are three types of sex workers in Melbourne: the higher-class "call girls," the
prostitutes who work in brothels, and those who work the streets. 9 Many of those
working the streets have serious drug addiction problems and are the ones who
most often find themselves on Popovic's Tuesday afternoon list.2° One of the aims
of the court is to move offenders from the streets to the brothels.21 From a harm
reduction perspective, according to Popovic, such a move represents a positive step
for offenders because the brothels pose fewer dangers as it concerns matters of
health and safety.22 However, this does not represent an endorsement of brothels,
only an acceptance that reduced exposure to the hazards of life on the streets is a
preferable situation and thus a worthy if modest goal.23
The same sort of thinking informs contrasting perspectives on the
appropriateness of needle-exchange programs.24 With respect to drug control, harm
minimization is often invoked to support needle-exchange programs, a drug control
strategy practiced in both Canada and Australia, among other places. 25 Catherine
Rynne, the first treatment coordinator of the Sydney drug court, speaks proudly of
Australia's "needle- and syringe-exchange programs," which, according to Rynne,
"have left us with one of the lowest rates of HIV infection among injecting drug
users in the world., 26 Similarly, the Canadian cities of Toronto and Vancouver both
have needle-exchange programs.27 Vancouver even has a "safe injection site" or
14. See infra notes 15-23, 25, 36-37 and accompanying text.
15. NOLAN, supra note 1, at 103.
16. Id. at 85.
17. Id.
18. See infra notes 19-23 and accompanying text.
19. NOLAN, supra note 1, at 103.
20. Id.
21. Id.
22. Id.
23. Id.
24. See, e.g., UN Backs Australia's Asia AIDS Fight, SYDNEY MORNING HERALD, May 3, 2009,
available at http://www.smh.com.au/world/un-backs-australias-asia-aids-fight-20090502-aqvm.htm
(describing Australia's needle exchange programs as a "good model" for harm reduction programs).
25. NOLAN, supra note 1, at 103; Dawn Moore, Translating Justice and Therapy: The Drug
Treatment Court Networks, 47 BRIT. J. CRIMINOLOGY 42, 47-48 (2007).
26. NOLAN, supra note 1, at 103.
27. Id.; Moore, supra note 25, at 47-48.
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"harm reduction hotel" called Insite, which provides addicts with a safe, sanitized,
and supervised space to inject their drugs of choice.28
Dr. Gabor Mate, a counselor at the Vancouver site, 29 offers an explanation of
the harm reduction philosophy that is central to the program. Dr. Mate illustrates
the philosophy by first discussing medical practices used to treat the harmful
consequences of cigarette smoking:
If a smoker comes to me with an infection, I will give him an inhaler to
suppress the inflammation in his lung and I will give him an antibiotic to
fight the infection. I didn't treat their disease of addiction. Nothing I
have done there will stop them from smoking. They will continue to
smoke, but I have reduced the harm of their habit to them. That is a
legitimate medical goal.3 °
The same perspective, according to Mate, informs the treatment of addicts who use
Insite's services.31 Here too the aim is to reduce the harm caused by a drug addicted
lifestyle.32
[T]he goal of harm reduction is to reduce the suffering from a certain
disease process and also to reduce the harm done to the addict by the
very judgmental and sometimes brutally negative social attitudes
towards them. So, [it reduces] harm in two ways. And thirdly, [we help]
to reduce the harm to society that arises from the problem of addiction;
because, to the extent that strewn needles aren't in the streets (because
people are using in here [Insite]), that reduces harm to society.33
Thus, Insite reduces harm by providing addicts with a safe site, clean needles, and
access to additional resources (including a detox program operating above the safe
injection facility) should they wish to stop using drugs altogether. 34 Though
supplied with clean needles, addicts who visit Insite must provide their own
drugs.
35
28. Moore, supra note 25, at 47 ("Vancouver is the first Canadian city to host a safe injection site,
needle exchange programme and harm-reduction hotel."); Vancouver Coastal Health, Insite-
Supervised Injection Site, http://supervisedinjection.vch.ca/ (last visited Feb. 18, 2010) ("Since opening
... in 2003, Insite has been a safe, health-focused place where people inject drugs and connect to health
care services .... ").
29. STAYING ALIVE (CBCNews television broadcast Mar. 13, 2009), available at
http://www.cbc.ca/fifth/2008-2009/staying-alive/dr-gabor-mate.html.
30. Id.
31. Id.
32. Id.
33. Id.
34. See Vancouver Coastal Health, Supervised Injection Site-Services,
http://supervisedinjection.vch.ca/services/services (last visited Feb. 18, 2010) (listing on-site services
including addiction counseling and withdrawal management).
35. Id.
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In another Canadian initiative, North American Opiate Medication Initiative
(NAOMI), launched in Vancouver and Montreal in 2005,36 addicts were actually
supplied with heroin in addition to being given clean needles. 37 A harm reduction
philosophy, once again, is invoked to justify this "heroin assisted treatment"
program.38 From this perspective, it is argued that since most hard-core drug
addicts are unemployed,39 they often resort to acquisitive crimes and/or prostitution
to pay for their drug habits. 40 By providing heroin, the program reduces the societal
harm caused by this persistent criminal activity. 4 1 Moreover, heroin supplied in a
sanitized clinical setting, it is argued, is likely to pose fewer health risks because
addicts are not "injecting street heroin (cut with other additives) in an unsafe
environment. 4 2 Therefore, not only is harm to society reduced by eliminating the
need to pay for drugs,43 but the dangers to the addict are minimized through the
provision of clean drugs and clean needles in a safe environment. 4
36. See Press Release, Can. Insts. of Health Research, North America's First Clinical Trial of
Prescribed Heroin Begins Thursday (Feb. 8, 2005), available at http://www.naomistudy.ca/pdfs/
NAOMI-release.pdf (describing the opening of the NAOMI throughout various locations in Canada).
37. Id.
38. See N. AM. OPIATE MEDICATION INITIATIVE (NAOMI), CAN. INSTS. OF HEALTH RESEARCH,
BACKGROUNDER 1-3 (2006), http://www.naomistudy.ca/pdfs/naomi-background.pdf (suggesting that
heroin assisted treatment increases social functioning and employment and decreases participation in
illegal activities).
39. See Benedikt Fischer et al., Illicit Opiates and Crime: Results of an Untreated User Cohort
Study in Toronto, 43 CAN. J. CRIMINOLOGY 197, 204 (2001) (noting that in a sample of 114 opiate users,
four out of five subjects were unemployed).
40. Id. at 206-07, 209 (reporting that nearly half of opiate users in the study were involved in theft,
burglary, fraud, or robbery, and one in ten subjects were involved in prostitution).
41. See Press Release, N. Am. Opiate Medication Initiative, Results Show that North America's
First Heroin Therapy Study Keeps Patients in Treatment, Improves Their Health and Reduces Illegal
Activity (Oct. 17, 2008), available at http://www.marketwire.com/press-release/North-American-
Opiate-Medication-Initiative-Naomi-Study-911088.html (noting that the percentage of NAOMI clinical
trial participants involved in illegal activity fell from seventy percent to approximately thirty-six
percent).
42. Candice C. Gartry et al., NAOMI: The Trials and Tribulations of Implementing a Heroin
Assisted Treatment Study in North America, HARM REDUCTION J., Jan. 21, 2009, at 10, available at
http://www.harmreductionjoumal.com/content/pdf/1477-7517-6-2.pdf (describing the benefits of heroin
assisted treatment). Resistance to the use of methadone remains widespread in the U.S., where even
though it is medically approved, "eight states still outlaw its use." Dan Small et al., Policy Makers
Ignoring Science and Scientists Ignoring Policy: The Medical Ethical Challenges of Heroin Treatment,
HARM REDUCTION J., May 2, 2006, at 9, available at http://harmreductionjoumal.com/content/pdf/l477-
7517-3-16.pdf.
43. See Fischer et al., supra note 39, at 210-12 (demonstrating that the cost to Canadian society
annually of illicit opiate addiction is approximately $5 million dollars); Press Release, N. Am. Opiate
Medication Initiative, supra note 41 (showing that participants in the NAOMI trial spent on average
over $1,000 less per month on drugs as a result of the treatment).
44. See Fischer et al., supra note 39, at 213 (noting marked improvements in the medical status of
the participants in the NAOMI clinical program); Rebecca L. Weiker et al., A Collaborative Evaluation
of a Needle Exchange Program for Youth, 26 HEALTH EDUC. & BEHAV. 213, 214 (1999) (discussing
studies that have shown "reduction in H1V risk at an individual level," and concluding that "needle
2010]
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Interestingly, NAOMI was originally meant to include several cities in the
United States; however, resistance to the harm reduction approach thwarted these
efforts. Between 1998 and 2000, a working group held a series of meetings to
determine possible locations for NAOMI in six Canadian and U.S. cities.4 5 "As
time went on, it became increasingly clear that no [U.S.] sites would be able to
participate nor could any [U.S.] funding be identified. ' '46 American officials have
also publicly opposed practices at Insite, a program U.S. Drug Czar John Walters
once referred to as "state sponsored ... suicide. 47
I. DRUG COURTS AND METHADONE MAINTENANCE
The difference between the U.S. and other countries with respect to a harm
reduction philosophy is also apparent in the differing styles of drug court programs
found internationally. The goal of most U.S. drug courts is "total abstinence," or
what some have referred to as "demand reduction."4 8 That is, clients (as they are
commonly called in drug court) usually must be both drug- and alcohol-free for a
specified period of time in order to graduate from a U.S. drug court program.49 In
contrast, other countries often view reduced use as a success, and clients can
sometimes graduate without being entirely drug-free. 50 A central treatment practice
in many programs outside of the U.S. is the prescription of a maintenance drug,
such as methadone or naltrexone. 51 A few American drug courts use methadone
exchange programs save lives and are an efficient use of prevention financial resources"); Press Release,
N. Am. Opiate Medication Initiative, supra note 41 (reporting the improvements in medical status found
in the NAOMI program).
45. Gartry et al., supra note 42, at 3.
46. Id.
47. Id. at 8.
48. Natasha Bakht, Problem Solving Courts as Agents of Change, 50 CRtM. L.Q. 224, 232 (2005);
Small et al., supra note 42, at 9.
49. See U.S. GOV'T ACCOUNTABILITY OFFICE, ADULT DRUG COURTS: EVIDENCE INDICATES
RECIDIVISM REDUCTIONS AND MIXED RESULTS FOR OTHER OUTCOMES 38 (2005), available at
http://www.gao.gov/new.items/d05219.pdf (listing different requirements for graduation of drug court
programs).
50. See NOLAN, supra note 1, at 104 (remarking on the harm reduction philosophies in Canada and
Australia in direct opposition to U.S. drug court practices); G. Alan Marlatt, Harm Reduction Around
the World: A Brief History, in HARM REDUCTION: PRAGMATIC STRATEGIES FOR MANAGING HIGH-RISK
BEHAVIORS 30, 30-45 (G. Alan Marlatt ed., 1998) (summarizing harm reduction programs in various
foreign countries and noting these countries' view that successful drug treatment can include simply a
reduction in drug use). See generally Patt Denning, PRACTICING HARM REDUCTION PSYCHOTHERAPY:
AN ALTERNATIVE APPROACH TO ADDICTIONS 100-01 (2000) (providing an in-depth discussion on what
it means to define success after instituting harm reduction drug treatments among drug abusers).
51. See, e.g., Daniela D'Ippoliti et al., Retention in Treatment of Heroin Users in Italy: The Role of
Treatment Type and of Methadone Maintenance Dosage, 52 DRUG & ALCOHOL DEPENDENCE 167, 167
(1998) (noting that methadone and naltrexone are commonly prescribed in Italy); Michael Gossop &
Marcus Grant, A Six Country Survey of the Content and Structure of Heroin Treatment Programmes
Using Methadone, 86 BRIT. J. ADDICTION 1151, 1153-54 (1991) (comparing methadone use in the U.K.,
Canada, the Netherlands, Thailand, France, and Australia).
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maintenance, 52 but this is actually rare in the U.S.53 Twenty percent of American
drug courts, in fact, specifically prohibit the use of any pharmacological
54interventions.
Importers of American-styled problem-solving courts are aware of the
differences between the United States and their countries as it concerns the
acceptability of methadone maintenance practices.55 Justice Paul Bentley, Canada's
first drug court judge, observes that, "unlike most [U.S.] drug courts, the Toronto
[Drug Treatment Court] incorporates methadone maintenance as part of its
treatment arsenal for heroin addicts. The abstinence model of most [U.S.] courts
does not permit methadone to be used., 56 Catherine Rynne observes the same in
Australia and associates this difference with the existence of public health systems
in both Australia and Canada. 57 As she puts it, "harm-minimization really is a
public health approach., 58 Because both countries are "welfare states" and have
"universal healthcare," Rynne believes the courts are able to offer a range of
services without requiring participants to pay for treatment, as sometimes happens
in U.S. programs. 59 Again, the primary treatment offered in these programs is
prescribed methadone.6 °
One finds a similar attitude toward the use of methadone in both Ireland and
Scotland.6' That is, judges identify harm-reduction as a defining treatment
52. James L. Nolan, Jr., Separated by an Uncommon Law: Drug Courts in Great Britain and
America, in DRUG COURTS: IN THEORY AND IN PRACTICE 89, 95 (James L. Nolan, Jr. ed., 2002). See
generally Andrew Tatarsky, Harm Reduction Psychotherapy: Extending the Reach of Traditional
Substance Use Treatment, 25 J. SUBSTANCE ABUSE TREATMENT 249, 249 (2003) (analyzing the
effectiveness of harm reduction treatments for drug users and reporting that in 2003, harm reduction
philosophy slowly gained credibility among policy experts and the medical field).
53. Paul Bentley, Canada's First Drug Treatment Court, 25 COMMONWEALTH L. BULL. 634, 642
(1999).
54. Nolan, supra note 52, at 95.
55. See, e.g., Bentley, supra note 53, at 642 (noting the Canadian view "that methadone is an
effective treatment option ... [even though] it does not fit the model of complete abstinence").
56. Id.
57. NOLAN, supra note 1, at 104.
58. Id.
59. Id.
60. See, e.g., Bakht, supra note 48, at 233 (describing Toronto's incorporation of methadone
maintenance as one option of its treatment services for heroin addicts); Miranda W. Langendam et al.,
The Impact of Harm-Reduction-Based Methadone Treatment on Mortality Among Heroin Users, 91 AM.
J. PUB. HEALTH 774, 774 (2001) (noting methadone's wide use for detoxification as well as maintenance
treatment in harm reduction programs).
61. See Michael Gossop et al., Outcomes After Methadone Maintenance and Methadone Reduction
Treatments: Two- Year Follow-Up Results from the National Treatment Outcome Research Study, 62
DRUG & ALCOHOL DEPENDENCE 255, 255 (2001) (describing methadone treatment throughout the
United Kingdom as an important part of the national treatment response); Eamon Keenan et al.,
Editorial, Managing Drug Misuse in General Practice: Republic of Ireland Has Set Up Scheme to
Regulate Methadone Prescribing by GPs, 319 BRIT. MED. J. 1497, 1497 (1999) (commenting on the use
of methadone maintenance in Ireland as a means to treat drug misuse); Andy D. Peters & Margaret M.
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philosophy 62 and see this philosophy as very different from the sort of thinking that
informs U.S. drug court programs. 63 Judge Gerard Haughton, who helped start
Ireland's first drug court, 64 understands that "most American models are based on
total abstinence from drugs and alcohol. 65 He explains, however, that in Ireland,
"the principal determining factor as to the success or otherwise of the drug court
was whether or not there was significant reduction in crime" and that the treatment
service working with the court uses a "methadone maintenance program" to meet
this objective.66 Haughton concedes that "while total abstinence might be an ideal
goal, it was unlikely to be realistic in many cases. 67 An important government
report issued in Ireland prior to the start of the Dublin drug court expresses a
similar sentiment.68 The report acknowledges that "whereas total abstinence is the
optimal object of a drugs treatment programme[,] the alternative system of
methadone maintenance should not be excluded" from Irish drug courts.69
In fact, in both Ireland and Scotland, methadone maintenance has been a
central part of their respective drug court programs.7 ° In Ireland, participants can
graduate from the program while still on a maintenance prescription for
Reid, Methadone Treatment in the Scottish Context: Outcomes of a Community-Based Service for Drug
Users in Lothian, 50 DRUG & ALCOHOL DEPENDENCE 47, 47-48 (1998) (explaining that the core feature
of treatment offered to opiate-dependent clients in one Scottish clinic is the prescribing of methadone).
62. E.g., Bentley, supra note 53, at 642-43 (discussing the various positive results Drug Treatment
Courts can instill upon society and suggesting that this alternative approach to treating addiction could
serve as a model).
63. See Bakht, supra note 48, at 251-52 (arguing that harm reduction philosophy could have a
beneficial role in the U.S. judicial system, and urging judges to adopt a therapeutic jurisprudence
perspective in specialized drug courts); Peggy Fulton Hora & Theodore Stalcup, Drug Treatment Courts
in the Twenty-First Century: The Evolution of the Revolution in Problem-Solving Courts, 42 GA. L.
REV. 717, 804-07 (2008) (arguing that U.S. drug treatment courts should revise their current
methodologies and become a standardized court system in order to better address the country's drug
problem).
64. GOV'T OF IR., THE FIRST REPORT OF THE DRUG COURT PLANNING COMMITrEE: PILOT PROJECT
3 (1999) (listing the members of the first Drug Court Planning Committee); NOLAN, supra note 1, at
125.
65. See NOLAN, supra note 1, at 125 (citing Judge Gerard Haughton, The Irish Experience of Drug
Courts, Presentation at the European Perspectives on Drug Courts Conference (Mar. 27, 2003)).
66. Id. at 125-26.
67. Id.
68. GOV'T OF IR., WORKING GROUP ON A COURTS COMMISSION, FIFTH REPORT: DRUG COURTS 64
(1998).
69. Id.
70. NOLAN, supra note I, at 126; see SUSAN ELEY ET AL., CRIME & CRIMINAL JUSTICE RESEARCH
PROGRAMME, THE GLASGOW DRUG COURT IN ACTION: THE FIRST SIX MONTHS 3 (2003), available at
http://www.scotland.gov.uk/Resource/Doc/47133/0029644.pdf (indicating that "[s]ubstitute prescribing
(using methadone) constituted the core treatment" in Scottish drug courts); MICHAEL FARRELL, COURTS
SERVICE: FINAL EVALUATION OF THE PILOT DRUG COURT 81 (2002), available at
http://www.justice.ie/en/JELR/finalevalpilotdrug.pdf/Files/finalevalpilotdrug.pdf ("[T]hree quarters of
the participants [in the Irish Drug Court program] are receiving methadone maintenance .... ").
[VOL. 13:31
HARM REDUCTION AND THE AMERICAN DIFFERENCE
methadone.7' While participants may be encouraged to "come off the methadone,"
as a Dublin probation officer explains, it is not required in order to "graduate from
the drug court program. 72 The importance of methadone treatment in the Glasgow
program is illustrated by the story of a delegation of Russian officials who visited
the Glasgow drug court. The visit evidently made it very clear to the Russians that
the Scottish drug court model was not transferable to a Russian context, due in part
to the court's use of methadone in treating offenders.73 Moira Price, program
director of the Glasgow drug court, recalls the visit of the Russian delegation:
We use methadone to a great extent here in our treatment, and
methadone is an illicit drug in Russia. So ... where we'd use methadone
as an alternative therapy, they just could not use that at all.... They just
could not get their heads around the concept of substitute prescribing as
a way to deal with addicts. They seemed to think the way to deal with
addicts was work therapy in prison.74
As in Scotland, Ireland, Canada, and Australia, methadone maintenance is
often a main staple of the treatment program associated with England's drug court
and drug court-like programs. 75 Such an orientation is attributable in no small
measure to Britain's particular history of drug control,76 in which doctors have
71. NOLAN, supra note 1, at 126. See generally Shane Butler, A Tale of Two Sectors: A Critical
Analysis of the Proposal to Establish Drug Courts in the Republic of Ireland, in CRIMINAL JUSTICE IN
IRELAND 407, 407-18 (Paul O'Mahony ed., 2002) (detailing Ireland's history of therapeutic treatment
for drug offenders, wherein abstinence is not the primary goal).
72. NOLAN, supra note 1, at 126.
73. Id. This is not surprising given general attitudes toward methadone in Russia. See, e.g., Small et
al., supra note 42, at 9 ("[M]ethadone is still treated as a pariah drug in many parts of the world. Entire
nations (e.g. Russia and India) today forbid [use of methadone] in addiction treatment ... .
74. NOLAN, supra note 1, at 126.
75. Id. at 58, 103-04, 126 (noting the importance of methadone in Canadian, Australian, Irish, and
Scottish drug courts); see, e.g., SUSAN ELEY ET AL., THE GLASGOW DRUG COURT IN ACTION: THE FIRST
SIX MONTHS 46 (2002) (stating that substitute prescribing with methadone "constituted the core element
of treatment service in practice" in Glasgow drug courts); Paul O'Mahony, Introduction, in CRIMINAL
JUSTICE IN IRELAND, supra note 71, at 421, 424 ("[Ireland's] greatly enlarged methodone programme
... has helped stablize the lives of many [criminal] heroin addicts ...."); Benedikt Fischer et al.,
Compulsory Drug Treatment in Canada: Historical Origins and Recent Developments, 8 EUR.
ADDICTION RES. 61, 63 (2002) (indicating methadone treatment has been used to varying degrees in
Canadian drug courts); Susan F. Tapert et al., Harm Reduction Strategies for Illicit Substance Use and
Abuse, in HARM REDUCTION: PRAGMATIC STRATEGIES FOR MANAGING HIGH-RISK BEHAVIORS, supra
note 50, at 145, 153 (citing Ingrid Reynolds & Dennis Magro, The Use of Methadone as a Treatment
Tool for Opiate Addicts: A Two-Year Follow-Up Study, 2 MED. J. AUSTL. 560, 561-62 (1976))
(indicating Australia has seen reduced crime and enhanced health following introduction of methadone
maintenance program).
76. NOLAN, supra note I, at 58. See generally Geoffrey Pearson, Drug-Control Policies in Britain,
in CRIME AND JUSTICE: A REVIEW OF RESEARCH 167, 173-84 (Michael Tonry ed., 1991) (discussing the
integral role medical professionals have played in efforts to control drugs in Britain); Trevor Bennett,
The British Experience with Heroin Regulation, 51 LAW & CONTEMP. PROBS. 299, 300-11 (1988)
(providing a general history of substitute prescribing for treatment of opiate addiction in Britain).
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played a more central role,77 and where providing maintenance drugs for the "stable
addict" has been a more common practice. 78 Doctors can still prescribe heroin in
the U.K.,79 though in recent years methadone has become the preferred
maintenance drug. 80 The important point here is that from a British perspective,
prescribing for maintenance purposes, given Britain's particular history of drug
control, is not unusual. 8' Given this history, it is not surprising that methadone
maintenance is a central feature of treatment practices in U.K. drug courts.
82
II. CULTURAL DIFFERENCE AND AMERICAN EXCEPTIONALISM
It should be noted that while the British are comfortable with a harm
reduction philosophy in which a medical doctor oversees treatment-the central
component of which is the prescription of a maintenance drug-they are much less
comfortable with the sort of therapeutic, self-help treatment that is often part of
American drug court programs. 83 In interviews with British judges and other
problem-solving court officials, I discovered high levels of discomfort with the
confessional, expressive style of the group therapy format.84 As a drug court judge
in London explains, "Brits won't talk to each other in the free and easy, relaxed,
and very open way that Americans will talk to each other." 85 This is particularly the
case among British men for whom this kind of discourse "doesn't come naturally,"
but rather is viewed as "a sign of weakness. '86 According to this judge, the only
way British men can speak in such an open manner is "when they get very drunk,"
a method unlikely to find much support in a criminal justice program aimed at
reducing substance misuse.
87
77. NOLAN, supra note 1, at 58; see Pearson, supra note 76, at 167 ("The 'British system' of drug-
control and treatment policies [has allowed] a central role for medical practitioners and treatment
philosophies .... ).
78. NOLAN, supra note 1, at 58; see Nolan, supra note 52, at 95-96 (describing the prescription of
maintenance drugs in Britain).
79. GERRY V. STIMsON & NICKY METREBIAN, JOSEPH ROWNTREE FOUNDATION, PRESCRIBING
HEROIN: WHAT IS THE EVIDENCE? 1, 3-4 (2003), available at http://www.jrf.org.uk/sites/files/jrf/
1859350836.pdf.
80. Id. at 7-8; Bennett, supra note 76, at 308-09.
81. See generally PHILIP BEAN, THE SOCIAL CONTROL OF DRUGS 130-48 (1974) (disucssing the
important role the medical community has historically played in the social control of drugs in the U.K.).
For a discussion of the differences between the U.K. and the U.S. concerning their respective histories of
drug control, see Nolan, supra note 52, at 93-98.
82. See, e.g., Nolan, supra note 52, at 95 (noting that methadone prescription is typical in British
drug courts).
83. NOLAN, supra note 1, at 58.
84. Id.
85. Id.
86. Id.
87. Id.
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An official with Scotland's first drug court observes much the same: "It's just
hard to picture many Scots standing up in a group and saying all the things that
you're meant to accept.... And that can only be cultural; it's just that we're
reticent." 88 Like the London judge, the Scottish official observes that the only way
Scots would behave in such a manner would be if they were intoxicated: "We don't
like speaking up, particularly in front of groups. ... I'd have to be drunk to stand
up in a group and say I'm an alcoholic.... If I was sober, nothing on earth would
induce me to stand up among a crowd of strangers and talk about myself."
89
Practices in these other countries, then, are characterized less by the
therapeutic self-help format of American programs, and more by a clinical, medical
model-an important feature of which is methadone maintenance. 90 Such practices
are in keeping with the overall treatment philosophy of harm reduction that is in
place in these other countries.91 Just as the British have been reluctant to embrace
self-help treatment modalities that have become popular in the U.S., Americans too
have been hesitant to embrace harm reduction as a guiding treatment philosophy. 92
Instead, at least as it concerns drug courts, the U.S. prefers a total abstinence or
demand reduction approach,93 an orientation that practitioners in the other countries
find unrealistic.
94
88. Id. at 133.
89. Id.
90. Id. at 135. Compare Keith Humphreys et al., Self-Help Organizations for Alcohol and Drug
Problems: Toward Evidence-Based Practice and Policy, 26 J. SUBSTANCE ABUSE TREATMENT 151, 155
(2004) (noting that many believe all U.S. substance abuse treatment programs are based on the self-help
format), and Keith Humphreys, Professional Interventions that Facilitate 12-Step Self-Help Group
Involvement, 23 ALCOHOL RES. & HEALTH 93, 93 (1999) (indicating Alcoholics Anonymous "continues
to be the most widely accessed resource for people with alcohol problems" in the U.S.), with UK DRUG
POLICY COMM'N, REDUCING DRUG USE, REDUCING REOFFENDING: ARE PROGRAMMES FOR PROBLEM
DRUG-USNG OFFENDERS IN THE UK SUPPORTED BY THE EVIDENCE? 37 tbl.4 (2008) (indicating the
relative under-utilization of the 12-step program by problem drug-using offenders in England, Wales,
and Scotland), and PETER REUTER & ALEX STEVENS, UK DRUG POLICY COMM'N, AN ANALYSIS OF UK
DRUG POLICY: A MONOGRAPH PREPARED FOR THE UK DRUG POLICY COMMISSION 77-78 (2007)
(describing generally the various clinical harm reduction models utilized in the U.K., including
methadone maintenance).
91. NOLAN, supra note 1, at 135; see, e.g., Jean Long, Service Providers' Views on Harm
Reduction Services, NEWSL. OF THE DRUG MISUSE RES. DIVISION (Health Research Board, Dublin, Ir.),
Nov. 2004, at 11-12, available at http://www.drugsandalcohol.ie/11125/l/Drugnet_12.pdf (reviewing
harm reduction practices in Ireland).
92. NOLAN, supra note 1, at 58. Compare Brian Wells, Narcotics Anonymous (NA) in Britain: The
Stepping Up of the Phenomenon, in 2 HEROIN ADDICTION AND THE BRITISH SYSTEM: TREATMENT AND
POLICY RESPONSES 167, 167-69 (John Strang & Michael Gossop eds., 2005) (discussing the
development of self-help programs in England, and noting the cynical view of many British drug
treatment professionals toward self-help programs), with PHILIP BEAN, DRUGS AND CRIME 130 (2d ed.
2004) (providing a side-by-side comparison of features between the U.S. drug court model and the Drug
Testing and Treatment Orders in the U.K.), and Butler, supra note 71, at 415 (discussing the American
refusal to view methadone prescribing as an acceptable treatment modality).
93. See TIM MCSWEENEY ET AL., INST. FOR CRIMINAL POLICY RESEARCH, THE TREATMENT AND
SUPERVISION OF DRUG-DEPENDENT OFFENDERS: A REVIEW OF THE LITERATURE PREPARED FOR THE
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In full agreement with the Scottish official cited above, I believe that these
differences are attributable, in part, to distinctive cultural predilections, and are
reflective of differing "legal accents" found in the six countries. In other words, a
preference for a harm reduction model is indicative of the more moderate
orientation of the other countries-one that stands in contrast to the bold and
enthusiastic disposition of American practitioners.95 Australian criminologist, Arie
Freiberg, observes: "Where the United States treads boldly, rapidly, and sometimes
foolishly, Australia tiptoes carefully, slowly, and most times reluctantly.,
96
Arguably, the slow, modest, and cautious qualities of the Australians are also
evident in the four other non-U.S. common law countries considered here.
This contrast with the U.S. is even reflected in the nomenclature used to
describe these courts, at least in the early years of this international legal
movement. 97 That is, some outside of the U.S. were reluctant to embrace the
concept of problem-solving, preferring instead the more modest expression
problem-oriented.98 In 2001, Arie Freiberg noted that, at the time, there was "no
generally accepted terminology" regarding these new court innovations.99 Freiberg
preferred problem-oriented, which "is slightly less hubristic" than problem-
solving l00 Australian criminologist John Braithwaite has also used the term
problem-oriented, as has Susan Eley in her analysis of the Toronto K Court; she
notes that problem-solving is the terminology used "in the American literature." '10 1
In spite of this initial reluctance, problem-solving has become the preferred term
internationally. 10 2 Nevertheless, the resistance, if only initial and short-lived, is still
telling.
UK DRUG POLICY COMMISSION 34 (2008) ("The vast majority [of U.S. drug courts] ... operate
abstinence-based treatment philosophies .... "). See generally BEAN, supra note 92, at 120-22 (detailing
the development and appeal of drug courts in the U.S.).
94. See, e.g., BEAN, supra note 92, at 122 (noting that, in general, the European perspective is
suspicious of the evangelical approach and the abstinence model that is used in the U.S.).
95. NOLAN, supra note 1, at 139-42, 172.
96. Arie Freiberg, Three Strikes and You're Out-It's Not Cricket: Colonization and Resistance in
Australian Sentencing, in SENTENCING AND SANCTIONS IN WESTERN COUNTRIES 29, 53 (Michael Tonry
& Richard S. Frase eds., 2001).
97. NOLAN, supra note 1, at 102-03.
98. Id.; see infra notes 100-01 and accompanying text.
99. NOLAN, supra note 1, at 103; Arie Freiberg, Problem-Oriented Courts: Innovative Solutions to
Intractable Problems?, II J. JUD. ADMIN. 8, 9 (2001).
100. NOLAN, supra note 1, at 103; Freiberg, supra note 99, at 25 n.5.
101. NOLAN, supra note 1, at 103; John Braithwaite, Restorative Justice and Therapeutic
Jurisprudence, 38 CRIM. L. BULL. 244, 246 (2002) ("[T]he most solid common ground between
Therapeutic Jurisprudence and Restorative Justice is that they are both part of a return to problem-
oriented adjudication."); Susan Eley, Changing Practices: The Specialised Domestic Violence Court
Process, 44 How. J. CRIM. JUST. 113, 113 (2005) ("[P]roblem-oriented courts (or problem-solving
courts in the American literature) ... are considered to be therapeutic jurisprudence.").
102. NOLAN, supra note 1, at 103; see, e.g., Bakht, supra note 48, at 225 (using the term problem-
solving when referring to Canadian drug courts); Andrew Phelan, Solving Human Problems or Deciding
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It reflects a perspective held by many outside of the U.S. that these courts will
not solve all of society's problems; they are not a panacea, as a number of
American practitioners often seem to suggest. 10 3 Those in the non-U.S. regions
harbor fewer illusions that the perennial problems addressed in these courts will
ever be fully solved. 1° 4 Arie Freiberg acknowledges that problem-oriented in
contrast to problem-solving represents a view that "is slightly more pessimistic than
[that of] American promoters of this concept."' 10 5 Freiberg sets himself apart from
the Americans in another sense when he writes that though he "can be identified as
a supporter of the problem-[solving] ... experiment," he is "not messianic about
it,''1°6 a not very subtle allusion to attitudes found in the U.S.'0 7 Jocelyn Green, a
member of the Ministry of Justice in the U.K., thinks Frieberg's preference for
using the term problem-oriented to characterize these courts "is a good point" and
notes that in England and Wales, "they're quite realistic about what they believe
these courts can achieve."'10 8 Compared to the U.S., Green believes the U.K. is
more realistic.' 0 9
III. HARM REDUCTION AND THE MEANING OF SUCCESS
One manner in which this "more realistic" perspective is revealed is in
perceptions of what constitutes success." l0 One of the early applications of the drug
Cases? Judicial Innovation in New York and Its Relevance to Australia: Part II, 13 J. JUD. ADMIN. 137,
145 (2004) (using the term problem-solving when referring to Australian drug courts).
103. Compare Press Release, Oregon Dep't of Human Servs., 2009 Marks the 20th Anniversary of
the First Drug Court in the Nation (May 13, 2009), available at http://www.oregon.gov/DHS/news/
2009news/2009-0513.pdf (reflecting the notion that drug courts are a revolution), and NEW JERSEY
JUDICIARY, THE FACTS ARE IN . . . DRUG COURTS WORK (2009) (declaring that drug courts are a
revolution), with GOV'T OF IR., supra note 68, at 13 ("Drug courts are not a panacea ... [and] are not a
universal remedy for the drug problem."), and 08 SCOT. PARL. DEB. (No. 15) (2001) 1265 (noting that
drug courts are only a part of the solution to the problem of substance abuse).
104. NOLAN, supra note 1, at 148 (relating opinions from various scholars that other countries are
more realistic about what these courts can achieve).
105. Freiberg, supra note 99, at 25 n.5.
106. Arie Freiberg, Professor, University of Melbourne, Specialized Courts, and Sentencing, Paper
Presented at the Probation and Community Corrections: Making the Community Safer Conference 6
(Sept. 2002), available at http://www.aic.gov.au/events/aic%20upcoming%20events/2002/-/media/
conferences/probation/freiberg.ashx.
107. Id. (comparing Frieberg's moderate support, withstanding the results of drug court evaluations,
to the resolve of the Conference of Chief Justices and State Court Administrators in the U.S. to broadly
integrate the methods in the drug courts into the administration of justice).
108. NOLAN, supra note 1, at 148.
109. Id.
110. Compare U.S. GOV'T ACCOUNTABILITY OFFICE, supra note 49, at 38 (indicating that
abstinence is part of U.S. drug court completion requirements), and Hora & Stalcup, supra note 63, at
761-62 (describing abstinence as a goal of U.S. treatment programs), with PAUL TURNBULL ET AL.,
HOME OFFICE RESEARCH, DEVELOPMENT AND STATISTICS DIRECTORATE, DRUG TREATMENT AND
TESTING ORDERS-THE 18-MONTH EVALUATION 1 (1999) (highlighting the reduction in drug use as a
result of drug treatment and testing orders in the U.K.), and MATRIX KNOWLEDGE GROUP, MINISTRY OF
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court model in the U.K. was Drug Treatment and Testing Orders (DTTOs)."'
Inspired by the U.S. drug court model and launched in 1998, DTTOs were first
tested out as a pilot scheme in Gloucestershire, Liverpool, and Croydon (South
London). I"2 Upon completion of the pilot, the Home Office declared DTTOs a
success and rolled them out nationally, as indicated in the following press release
issued in the fall of 2000:
The national roll-out follows three successful pilot schemes in Croydon,
Liverpool and Gloucestershire which ran from 1 October 1998 to 31
March 2000.... [T]he average number of crimes committed per month
by offenders on DTTOs fell dramatically from 107 to 10, while their
average weekly spend on illegal drugs showed a significant reduction
from £400 to f30.113
Notice that offenders in these programs were still using drugs and were still
participating in criminal activity, albeit at reduced rates. 1 4 From a British
perspective, however, this is still interpreted as a success."l5 As Paul Hayes, Chief
Probation Officer of the Southeast London Probation Service, explains: "the
indications are that everything we hoped for in terms of reduced offending and
reduced drug use is true. Across the three pilots, instead of people averaging thirty
acquisitive crimes a week they are averaging three. So, in those terms it is clearly a
success, [even though] everyone is testing positive for continued drug use. ' As
noted above, such a position has historical precedence."l 7 As Hayes explains, "[t]he
whole harm reduction philosophy has dominated U.K. drug policy for a long
time."' 18
This medically informed perspective can sometimes be very difficult for
Americans to understand. Philip Bean, a British criminologist who for years studied
the U.S. drug court movement on behalf of the U.K. Home Office, made note of
this difficulty when speaking to a group of British and American criminal justice
professionals:
I think it's sometimes very difficult for North Americans to realize that
it's still possible in Britain for heroin to be prescribed as maintenance
and is often prescribed. I'm not talking about methadone; I'm talking
JUSTICE, DEDICATED DRUG COURT PILOTS: A PROCESS REPORT 8 (2008) (noting that among the aims of
drug courts in the U.K. is a reduction in drug use as opposed to abstinence).
111. MIKE HOUGH ET AL., THE IMPACT OF DRUG TREATMENT AND TESTING ORDERS ON
OFFENDING: TWO-YEAR RECONVICTION RESULTS 1 (2003).
112. Id.
113. Press Release, Home Office, New Powers for Courts to Help Tackle Drug Related Crime (Sept.
29, 2000).
114. Id.
115. Nolan, supra note 52, at 96.
116. Id.
117. See supra note 76 and accompanying text.
118. Nolan, supra note 52, at 96.
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about heroin. There isn't the culture in Britain as there is occasionally in
certain parts of America to talk in terms of complete abstinence of all
drug substances, including alcohol. I think that really does make a
difference because the debate in Britain isn't about abstinence, it's about
harm reduction. 1 9
A similar perspective regarding success can be found in Australian drug
courts. There too, program graduation requirements tend to be less restrictive than
are those in U.S. drug court programs. 120 Libby Wood, magistrate of the Perth drug
court, explains: "We don't expect participants to be totally drug free.... We do
tolerate some cannabis use. And we do tolerate [use of] some prescription
drugs.' 12 1 Requirements in Canadian drug courts are likewise less demanding.
122
Natasha Bakht and Paul Bentley highlight this quality of Canadian courts in direct
contrast to U.S. drug court practices.
In the United States almost all drug courts either prohibit or strongly
discourage the use of both illegal drugs and alcohol by drug court
participants. By way of contrast, in Toronto, where participants have
achieved a positive lifestyle change, have stopped using crack/cocaine,
heroin and other non-medically prescribed drugs[,] and have at least one
marijuana-free urine sample, they may be permitted to complete Phase I
of the program at the discretion of the DTC team.
123
Different understandings of what constitutes success are also evident in
needle exchange and heroin assisted treatment programs. 124 In these programs,
perceptions of what represents success need not even include reductions in drug
use. 125 Dr. Gabor Mate argues that there are multiple successes at Insite, even in the
absence of visible efforts to stop or reduce drug use.
119. Id.
120. Compare Hora & Stalcup, supra note 63, at 761 (describing the requirement of abstinence from
illegal drugs as an objective of U.S. drug court programs), with NOLAN, supra note 1, at 104 (describing
the Australian approach that tolerates continued drug use).
121. NOLAN, supra note 1, at 104.
122. Id.; see Bakht, supra note 48, at 232 (comparing the Canadian and American approaches).
123. Bakht, supra note 48, at 232.
124. See NOLAN, supra note 1, at 103 (discussing the success of an Australian needle exchange
program, including drastically reduced HIV infections among drug users); N. AM. OPIATE MEDICATION
INITIATIVE (NAOMI), supra note 38, at 2-3 (noting that in a Swiss heroin assisted treatment program,
more than half of the dropouts switched to other treatments or went drug-free); Ernest Drucker,
Editorial, Insite: Canada's Landmark Safe Injecting Program at Risk, HARM REDUCTION J., Aug. 9,
2006, at 2, http://www.harmreductionjoumal.com/content/pdf/1477-7517-3-24.pdf (noting the success
of the Insite needle exchange program in reducing the number of people injecting in public, the presence
of injection related litter, and needle sharing); Nolan, supra note 52, at 96 (noting the success of heroin
assisted treatment in decreasing acquisitive crimes); Press Release, N. Am. Opiate Medication Initiative,
supra note 41 (noting the success of heroin assisted treatment in decreasing spending on illegal drugs).
125. See, e.g., NOLAN, supra note 1, at 104 (regarding reduced crime as a success); Drucker, supra
note 124, at 2 (regarding safe injection practices and reduced break-ins as a success); Nolan, supra note
52, at 96 (regarding reduced crime as a success despite continuing drug use at reduced levels).
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If somebody is willing to receive HIV treatment when they need it, that
is a success. If somebody regularly uses the facility where they use clean
needles, so that they [do not] get abscesses that get ceded to their brains
or their heart valves or their spinal column or their hip joints, that is a
success. If somebody develops a trusting relationship with caregivers,
who all their lives they have mistrusted caregivers because their very
earliest caregivers have abused them, that is a success. So, there are
many successes. 126
CONCLUSION
Thus, one finds in England, Scotland, Ireland, Australia, and Canada a basic
philosophical approach that stands in contrast to ideas and practices more common
in the U.S. 27 As manifested in needle exchange programs, "harm reduction hotels,"
heroin prescription clinics, 128 and in the differing orientations of such problem-
solving courts as drug courts and prostitution courts, 129 harm reduction is a
dominant philosophy outside of the U.S. 130 Practitioners in both the U.S. and in the
five other common law countries recognize the American difference, in this regard,
and sometimes wish for greater acceptance in the U.S. of harm reduction ideas and
practices. However, it is important to recognize that this philosophy is reflective
of distinctive cultural dispositions.132
While it is beyond the scope of this Article to delineate these cultural
determinates, a harm reduction philosophy is more in keeping with the careful,
moderate, and reserved jurisprudential sensibilities of the five common law
countries outside of the U.S., while the demand reduction approach (along with the
popularity of such treatment modalities as self-help therapy groups) is
commensurate with the more optimistic, bold, and enthusiastic tendencies of
contemporary American legal culture. 133 Those wishing to advance a harm
reduction philosophy and concomitant practices in the U.S. do well to be aware of
these cultural differences.'34 Harm reduction is a treatment philosophy with
126. STAYING ALIVE, supra note 29.
127. NOLAN, supra note 1, at 136.
128. See supra notes 24-28, 37 and accompanying text.
129. See supra notes 15, 50 and accompanying text.
130. See supra notes 3-4 and accompanying text.
131. See supra note 103 and accompanying text.
132. See supra notes 83, 88, 95 and accompanying text (suggesting that Brits and Scots are not
comfortable with the expressive elements and boldness of thinking in American drug treatment
programs focused on achieving abstinence).
133. See supra notes 90-94 and accompanying text. See generally NOLAN, supra note 1, at 136-51
(discussing the distinct characteristics of the American approach).
134. See id. (describing the cultural differences); John Christoffersen, Needle Exchange Programs
Struggle with Funding Despite Positive Studies, USA TODAY (Mar. 11, 2007), available at
http://www.usatoday.com/news/health/2007-03-11-needleexchange._N.htm (noting resistance in the U.S.
to funding harm reduction programs such as needle exchange programs); supra note 47 and
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significant cultural roots.135 Such roots cannot be ignored when considering the
potential transferability of this philosophy and related practices to a very different
cultural context.1
36
accompanying text (describing the philosophy of Americans opposed to harm reduction programs such
as heroin assisted clinics).
135. See supra note 133 (discussing the different cultural dispositions of the U.S. and countries that
embrace harm reduction).
136. See NOLAN, supra note 1, at 166 (noting the need for adaptation of imported philosophies given
perceived differences).
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